詳細(xì)介紹
IN VIVO TRANSFECTION KITS: PEG-Liposome, Nanoparticle, Polymer, Lipid, Tissue-targeted
貨號:5011, LIPID In Vivo Transfection Kit, 1.5 mL (30 injections)¥12530元
貨號:5021, POLYMER In Vivo Transfection Kit, 1.5 mL (30 injections) ¥13090元
貨號:5031 ,NANOPARTICLE In Vivo Transfection Kit, 1.5 mL (30 injections) ¥13370元
貨號:5041, PEG-Liposome In Vivo Transfection Kit, 1.5 mL (30 injections) ¥13650元
貨號:5051,PANCREAS-targeted In Vivo Transfection Reagent - 1.5 mL (30 injections)¥13930元
貨號:5061 LIVER-targeted In Vivo Transfection Reagent - 1.5 mL (30 injections) ¥13930元
貨號:5071 KIDNEY-targeted In Vivo Transfection Reagent - 1.5 mL (30 injections) ¥13930元
LIPID-based In Vivo Transfection Kit for Rodents (Mouse, Rat)
- Cationic lipid liposome-based siRNA and plasmid DNA in vivo delivery reagent
- Efficient delivery to the liver, pancreas, kidney, and certain tumor types via systemic administration
- Complete product support information is available at: LIPID In Vivo Transfection Kit
Figure 1. Systemic administration (i.v.) of Lipid-based In Vivo reagent conjugated with siRNA targeting Lamin A/C mRNA or non-silencing control siRNA following the recommended protocol. Tissues were collected and RNA isolated 48 hours after first injection. Samples were analyzed by qRT-PCR for Lamin A/C gene expression levels. Ribosomal RNA levels were used to normalize the Lamin A/C data. Data are means ± SD (n=6).
Figure 2. Intratumoral administration (i.t.) of Lipid-based In Vivo reagent conjugated with siRNA targeting Lamin A/C mRNA or non-silencing control siRNA following the recommended protocol. Tissues were collected and RNA isolated 48 hours after first injection. Samples were analyzed by qRT-PCR for Lamin A/C gene expression levels. Ribosomal RNA levels were used to normalize the Lamin A/C data. Data are means ± SD (n=6).
POLYMER-based In Vivo Transfection Kit for Rodents (Mouse, Rat)
- Biodegradable polymer-based in vivo reagent
- Efficient delivery to the lung, liver, kidney, and spleen via systemic administration
- Complete product support information is available at: POLYMER In Vivo Transfection Kit
Figure 3. Systemic administration (i.v.) of Polymer-based In Vivo reagent conjugated with siRNA targeting Lamin A/C mRNA or non-silencing control siRNA following the recommended protocol. Tissues were collected and RNA isolated 48 hours after first injection. Samples were analyzed by qRT-PCR for Lamin A/C gene expression levels. Ribosomal RNA levels were used to normalize the Lamin A/C data. Data are means ± SD (n=6).
Figure 4. Intratumoral administration (i.t.) of Polymer-based In Vivo reagent conjugated with siRNA targeting Lamin A/C mRNA or non-silencing control siRNA following the recommended protocol. Tissues were collected and RNA isolated 48 hours after first injection. Samples were analyzed by qRT-PCR for Lamin A/C gene expression levels. Ribosomal RNA levels were used to normalize the Lamin A/C data. Data are means ± SD (n=6).
NANOPARTICLE-based In Vivo Transfection Kit for Rodents (Mouse, Rat)
- Nanoparticle-based reagent
- Efficient delivery to the heart, lung, liver, pancreas, kidney, and multiple tumor types via systemic administration
- Complete product support information is available at: NANOPARTICLE In Vivo Transfection Kit
Figure 5. Systemic administration (i.v.) of Nanoparticle-based In Vivo reagent conjugated with siRNA targeting Lamin A/C mRNA or non-silencing control siRNA following the recommended protocol. Tissues were collected and RNA isolated 48 hours after first injection. Samples were analyzed by qRT-PCR for Lamin A/C gene expression levels. Ribosomal RNA levels were used to normalize the Lamin A/C data. Data are means ± SD (n=6).
Figure 6. Intratumoral administration (i.t.) of Nanoparticle-based In Vivo reagent conjugated with siRNA targeting Lamin A/C mRNA or non-silencing control siRNA following the recommended protocol. Tissues were collected and RNA isolated 48 hours after first injection. Samples were analyzed by qRT-PCR for Lamin A/C gene expression levels. Ribosomal RNA levels were used to normalize the Lamin A/C data. Data are means ± SD (n=6).
PEG-Liposome In Vivo Transfection Kit for Rodents (Mouse, Rat)
- PEGylated liposome based reagent
- Efficient delivery to the spleen, kidney, pancreas, liver, and multiple tumor types via systemic administration
- Complete product support information is available at: PEG-Liposome In Vivo Transfection Kit
Figure 7. Systemic administration (i.v.) of Liposome-PEG based In Vivo reagent conjugated with siRNA targeting Lamin A/C mRNA or non-silencing control siRNA following the recommended protocol. Tissues were collected and RNA isolated 48 hours after first injection. Samples were analyzed by qRT-PCR for Lamin A/C gene expression levels. Ribosomal RNA levels were used to normalize the Lamin A/C data. Data are means ± SD (n=6).
Figure 8. Intratumoral administration (i.t.) of Liposome-PEG based In Vivo reagent conjugated with siRNA targeting Lamin A/C mRNA or non-silencing control siRNA following the recommended protocol. Tissues were collected and RNA isolated 48 hours after first injection. Samples were analyzed by qRT-PCR for Lamin A/C gene expression levels. Ribosomal RNA levels were used to normalize the Lamin A/C data. Data are means ± SD (n=6).
Tissue-targeted In Vivo Transfection Reagents for Rodents (Mouse, Rat):
- LIVER-targeted in vivo reagent
- KIDNEY-targeted in vivo reagent
- PANCREAS-targeted in vivo reagent